AstraZeneca reported $2.12B in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Alcon AG ALC:SW USD 972M 6M
Amgen AMGN:US USD 1.59B 78M
Artemis Alpha ATS:LN GBP 507K 125K
AstraZeneca AZN:LN USD 2.12B 214M
AstraZeneca AZN:SS USD 2.12B 214M
Astrazeneca AZN:US USD 2.12B 214M
Bayer BAYN:GR EUR 4.25B 1.43B
Biogen BIIB:US USD 469.5M 14.5M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Eli Lilly And LLY:US USD 1.58B 148.6M
Fresenius FRE:GR EUR 7.75B 414M
Fresenius Medical Care FME:GR EUR 3.74B 326M
Galapagos GLPG:NA EUR 2.39M 240K
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Hikma Pharmaceutical HIK:LN USD 590M 62M
Merck MRK:GR EUR 2.15B 38M
Merk MRK:US USD 3.43B 715M
Novartis NOVN:VX USD 3.66B 92M
Orion ORNBV:FH EUR 136.1M 25.9M
Pfizer PFE:US USD 6.09B 2.58B
Philips PHIA:NA EUR 2.58B 135M
Recordati REC:IM EUR 154.92M 2.52M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Roche Holding ROG:VX 9.56B 717M